EP3221355A1 - COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES CD3 ABD FOLATE RECEPTOR 1 (FOLR1) AND PD-1 AXIS BINDING ANTAGONISTS